← Back to all treatments
JCI AccreditedGrade A Tertiary Hospital12,000++ Annual Neurosurgical Procedures

Medically reviewed by neurosurgery experts | Last updated: March 2025

Evidence-based: Content references NCCN, Chinese Neurosurgical Society guidelines.

Advanced Neurosurgery in China | Same International Standard, 40% Cost

Brain Tumor Resection, DBS, Minimally Invasive Spine Surgery at China's Top Tertiary Centers (JCI Accredited)

Start consultation

Brain Tumor Surgery

Conditions we treat:

Gliomas (GBM, oligodendroglioma); Meningiomas (skull base/sinus); Pituitary adenomas; Metastases; Pediatric tumors (medulloblastoma)

Awake craniotomy | 5-ALA fluorescence-guided resection | LITT laser ablation (minimally invasive)

Molecular pathology (IDH, MGMT); awake surgery for eloquent areas; 5-ALA fluorescence; LITT for deep lesions.

✓ Complex Cases WelcomeEloquent-area (Broca/motor cortex) glioma requiring awake surgery; skull base tumours (petroclival, foramen magnum) needing combined approach; recurrent meningioma requiring repeat surgery.High-volume centres experienced in complex skull base and functional zone tumours.
Consider Local Treatment FirstNon-eloquent superficial meningioma with Simpson grade I resection likely.Straightforward cases where your local hospital has sufficient volume.

Partner centres >800 glioma surgeries/year; intraoperative MRI; 92% total resection with 5-ALA; <3% postoperative aphasia.

Treatment plans

Awake craniotomy

Surgery
  • Fit: Eloquent-area tumours (speech/motor)
  • Tech: Real-time neurophysiology + fMRI navigation
  • Advantage: Maximal resection while preserving function
  • Leading centres >500 cases/year • 7–10 days stay
Start consultation

LITT (laser interstitial thermal therapy)

Minimally invasive
  • Fit: Deep-seated lesions; patients preferring minimally invasive
  • Tech: MRI-guided laser ablation
  • Advantage: No craniotomy; shorter stay
  • Available at top centres • 3–5 days stay
Start consultation

5-ALA fluorescence-guided resection

Surgery
  • Fit: High-grade gliomas
  • Tech: Intraoperative fluorescence; improved margin detection
  • Advantage: Higher total resection rate
  • Widely adopted at Grade 3A centres • 7–10 days stay
Start consultation

Functional Neurosurgery

Conditions we treat:

Parkinson's DBS | Drug-resistant epilepsy SEEG evaluation | Dystonia

ROSA robotic implant (<0.3mm accuracy) | Intraoperative neurophysiology | 1-year remote programming

DBS: Parkinson's (motor fluctuations), dystonia, essential tremor; OCD/depression (strict ethics). SEEG: preoperative evaluation for drug-resistant epilepsy, not treatment itself.

✓ Complex Cases WelcomeDrug-refractory Parkinson's with severe motor complications; bilateral GPi DBS for dystonia; drug-resistant epilepsy needing SEEG (>2 drugs failed).Centres with intraoperative neurophysiology and >2,000 DBS/year.
Consider Local Treatment FirstSimple tremor-only cases where local DBS centre has sufficient volume.Straightforward tremor with good local access.

Leading centres >95% intraoperative monitoring; >2,000 DBS/year; <0.3mm implant accuracy.

Treatment plans

DBS (deep brain stimulation)

Surgery
  • Fit: Parkinson's (motor fluctuations); dystonia; drug-resistant essential tremor; OCD/depression (strict ethics)
  • Tech: ROSA robot; bilateral implantation; intraoperative microelectrode recording
  • Advantage: ~90% symptom improvement; medication reduction
  • >2,000 DBS/year at leading centres • 7–14 days stay
Start consultation

SEEG (stereo-EEG)

Minimally invasive
  • Fit: Drug-resistant epilepsy preoperative evaluation (not treatment)
  • Tech: Robotic electrode placement; invasive monitoring; seizure onset localisation
  • Advantage: Precise preoperative mapping for resection
  • Epilepsy centres with SEEG programme • 14–21 days stay
Start consultation

Cerebrovascular Surgery

Conditions we treat:

Aneurysms; AVM; flow diversion

Endovascular vs open clipping; flow diverters; hybrid OR

Endovascular vs open clipping; flow diverters; hybrid OR for complex cases.

✓ Complex Cases WelcomeComplex aneurysm/AVM; need hybrid OR; high-volume vascular centre.
Consider Local Treatment FirstSimple, small incidental aneurysms in stable patients.

High-volume vascular centres; hybrid OR; morbidity <2%.

Treatment plans

Aneurysm clipping

Surgery
  • Fit: Wide-neck; complex geometry
  • Tech: Microsurgery; intraoperative angiography
  • Advantage: Durable exclusion; hybrid OR option
  • High-volume vascular centres • 7–14 days stay
Start consultation

Endovascular embolization

Minimally invasive
  • Fit: Favourable anatomy; fusiform aneurysms
  • Tech: Coiling; flow diverters; stents
  • Advantage: Minimally invasive; shorter recovery
  • Interventional neuroradiology teams • 3–7 days stay
Start consultation

Spine & Spinal Cord

Conditions we treat:

Disc herniation; foraminal stenosis; scoliosis; instability; revision

PELD full-endoscopic | 3D navigation | Degenerative vs deformity correction

PELD endoscopic; 3D navigation; degenerative vs deformity correction.

✓ Complex Cases WelcomeScoliosis Cobb >50°; revision surgery (prior failure); complex spine tumour requiring en bloc resection.Experienced in complex deformity and revision.
Consider Local Treatment FirstSingle-level disc herniation with PELD indication (widely available locally).Straightforward disc herniation may be suitable locally.

PELD >1,000/year; scoliosis correction; rapid discharge protocols.

Treatment plans

PELD (endoscopic spine surgery)

Minimally invasive
  • Fit: Disc herniation; foraminal stenosis
  • Tech: Full-endoscopic; day surgery possible
  • Advantage: 2–4 day stay; minimal soft-tissue damage
  • >1,000 PELD/year at spine centres • 2–4 days stay
Start consultation

Spinal fusion / deformity correction

Surgery
  • Fit: Scoliosis; instability; revision
  • Tech: 3D navigation; pedicle screws; biologics
  • Advantage: Stable correction; long-term outcomes
  • Complex deformity programmes • 5–10 days stay
Start consultation

Cost Comparison for Deep Brain Stimulation (DBS)

US Hospital
$75,000
UK Private
$55,000
MediLink China (incl. robot-assisted)
$18,000

Savings: $57,000 vs US | Includes: surgery, 7-day stay, monitoring, 1-year programming

Includes: surgery, 7-day stay, intraoperative monitoring, 1-year programming

Hidden costs

US: 4–6 month wait risk; DBS battery replacement ~$15k/5yr

China: flight, visa, escort (MediLink bundled)

Patient journey

Pre-op
Week 1: Diagnosis & surgical preparation

Day 1: Arrival, admission (MRI/CT review). Day 2–3: MDT (neurosurgery + imaging + pathology). Day 4–7: Surgery.

Surgery
Week 2: Early post-op recovery

Day 8–10: ICU → ward; imaging. Day 11–12: Mobilisation, function assessment (spine/DBS). Day 13–14: Discharge prep; records translation.

Recovery
Week 3–4: Rehabilitation (optional)

DBS: programming; Spine: physiotherapy.

Recommended hospitals

Beijing Tiantan Hospital, Capital Medical University
Huashan Hospital, Fudan University
West China Hospital, Sichuan University
View all hospitals

Why complex cases choose China: Technology adoption

TechnologyChina top centresWestern centres
ROSA surgery robot>85%30–40%
Intraoperative MRI>60%20–25%
Awake craniotomyRoutineSpecialist centres only
DBS intraoperative electrophysiologyStandardExtra booking

Sources: 2024 China neurosurgery equipment report vs OECD health statistics

DBS long-term management: Cross-border follow-up

Year 1 (in China)

  • • 1 week: first programming (inpatient)
  • • 1 month: parameter fine-tuning (remote video support)
  • • 3/6/12 months: regular follow-up

Year 2+ (in your country)

  • • Remote programming: patient uses home controller; Chinese doctor adjusts via secure VPN (local neurologist support may be required)
  • • 24/7 bilingual hotline for urgent support
  • • Medtronic/Boston Scientific devices: global warranty

Some countries require local neurologist sign-off for telemedicine.

China neurosurgery: Clinical innovation contributions

  • • 2023: World-first 5G remote DBS surgery (Beijing–Hainan)
  • • 2022: Chinese glioma guideline cited by NCCN
  • • 2021: Global highest ROSA volume (cumulative >5,000)
  • • >200 neurosurgery original papers/year to international journals

We are not a low-cost substitute — we are a high-value choice.

Not sure if you need surgery?

Get a second opinion from Chinese neurosurgeons. Remote review with video interpretation within 48 hours.

Get second opinion

Frequently asked questions

Is brain tumour surgery in China as safe as in the US?
China's top neurosurgery centres perform >10,000 brain tumor surgeries/year with outcomes comparable to US top-tier hospitals. Key safety metrics: <1.5% infection rate, 0.8% permanent neurological deficit. All partner hospitals are JCI-accredited, ensuring international standards.
What is the success rate of awake craniotomy in China?
Leading centres report >95% successful awake mapping and gross-total resection rates of ~92% with 5-ALA. Partner centres >500 awake cases/year; postoperative aphasia <3%.
How do Chinese neurosurgeons handle language barriers during surgery?
MediLink provides pre-op briefing and bilingual support. For awake surgery, interpreters coordinate with the neurophysiology team. Many surgeons have international training and use standardised protocols that minimise verbal communication during critical steps.
Can I get DBS programming adjusted in my home country after surgery in China?
Yes. DBS devices (Medtronic, Boston Scientific, Abbott) are globally compatible. We provide programming parameters and support remote coordination with your local neurologist. Some centres offer tele-programming.
How do I choose between awake craniotomy and LITT for my glioma?
Awake craniotomy: eloquent-area tumours (speech/motor); maximal resection with function preservation. LITT: deep-seated small lesions (thalamus, brainstem edge); no craniotomy; 2–3 day stay. Suitability depends on tumour location, size, and your preferences.
What happens if complications occur after I return home?
We coordinate with your local doctors and provide translated records. For DBS: devices are globally compatible; local neurologists can program. For surgical complications: we help arrange remote consultation with the China team and can support urgent follow-up if needed.

Surgery safety data (partner hospitals 2023–2024)

Postoperative infection: <1.5% (international ref: Lancet Global Health 2022 avg 2.3%). Intraoperative transfusion: <2% (literature: complex skull base 5–8%). 30-day reoperation: <1.2%. Permanent neurological deficit: <0.8% (IONM全覆盖).

* Individual risk varies by age, comorbidities, tumour location. Source: partner hospital quality reports.

Get treatment planUpload images for consultation

30 seconds to submit; expert reply within 48 hours